These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 31118602)

  • 61. Non-Small Cell Lung Carcinoma in Women: A Retrospective Cohort Study in Indonesia.
    Sutandyo N; Suratman E
    Acta Med Indones; 2018 Oct; 50(4):291-298. PubMed ID: 30630993
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinicopathologic characteristics of non-small cell lung cancer in patients with smoking-related chronic obstructive pulmonary disease.
    Maeda R; Tomita M; Usuda K; Uramoto H
    Gen Thorac Cardiovasc Surg; 2019 Feb; 67(2):239-246. PubMed ID: 30187259
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hand grip strength and chronic obstructive pulmonary disease in Korea: an analysis in KNHANES VI.
    Lee SH; Kim SJ; Han Y; Ryu YJ; Lee JH; Chang JH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2313-2321. PubMed ID: 28831248
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
    Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
    Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
    Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
    Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease.
    Chun EM; Kim SW; Lim SY
    Int J Chron Obstruct Pulmon Dis; 2015; 10():955-60. PubMed ID: 26028968
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
    Popat S; Liu SV; Scheuer N; Gupta A; Hsu GG; Ramagopalan SV; Griesinger F; Subbiah V
    JAMA Netw Open; 2022 May; 5(5):e2214046. PubMed ID: 35612853
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
    Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
    Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The association between combined non-cystic fibrosis bronchiectasis and lung cancer in patients with chronic obstructive lung disease.
    Kim YW; Jin KN; Heo EY; Park SS; Chung HS; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():873-9. PubMed ID: 26005340
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
    Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
    Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease.
    Shin SH; Park HY; Im Y; Jung HA; Sun JM; Ahn JS; Ahn MJ; Park K; Lee HY; Lee SH
    Int J Cancer; 2019 Nov; 145(9):2433-2439. PubMed ID: 30807641
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epidemiological analysis of progression-free survival (PFS) and overall survival (OS) in non-small-cell lung cancer patients in Republic of Macedonia.
    Risteski M; Crvenkova S; Atanasov Z; Isjanovska R
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):49-61. PubMed ID: 24566015
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Exploration of the treatment model for patients with advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease based on real-world data].
    Wang F; Xie XH; Lin XQ; Qin YY; Xie ZH; Zhang JX; Ouyang M; Zhou CZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 May; 43(5):450-454. PubMed ID: 32450634
    [No Abstract]   [Full Text] [Related]  

  • 75. High-intensity training and cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease and non-small-cell lung cancer undergoing lobectomy.
    Stefanelli F; Meoli I; Cobuccio R; Curcio C; Amore D; Casazza D; Tracey M; Rocco G
    Eur J Cardiothorac Surg; 2013 Oct; 44(4):e260-5. PubMed ID: 23892298
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Proportion and clinical features of never-smokers with non-small cell lung cancer.
    Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS
    Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Voluntary lung function screening to reveal new COPD cases in southern Italy.
    Capozzolo A; Castellana G; Dragonieri S; Carratù P; Liotino V; Vulpi MR; Marra L; Resta E; Intiglietta P; Resta O
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2035-2042. PubMed ID: 28744118
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk of chronic obstructive pulmonary disease in healthy individuals with high C-reactive protein levels by smoking status: a population-based cohort study in Korea.
    Lim SY; Zhao D; Guallar E; Chang Y; Ryu S; Cho J; Shim JY
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2037-2046. PubMed ID: 31564851
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognosis of smokers following resection of pathological stage I non-small-cell lung carcinoma.
    Sawabata N; Miyoshi S; Matsumura A; Ohta M; Maeda H; Sueki H; Hayakawa M; Okumura M; Sawa Y
    Gen Thorac Cardiovasc Surg; 2007 Oct; 55(10):420-4. PubMed ID: 18018606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.